Risk Factors and Outcomes Associated With Posttransplant Diabetes Mellitus in Kidney Transplant Recipients

Transplantation Proceedings

Volumn 42, Issue 5, 2010, Pages 1685-1689

  Siraj, E S ^a   Abacan, C ^a   Chinnappa, P ^a   Wojtowicz, J ^a   Braun, W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLITAZONE DERIVATIVE; GLUCOSE; INSULIN; METFORMIN; METHYLPREDNISOLONE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TACROLIMUS; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; OUTCOMES RESEARCH; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; STEROID THERAPY; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; CREATININE; CYTOMEGALOVIRUS INFECTIONS; DIABETES MELLITUS; GRAFT REJECTION; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROTEINURIA; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 77953659575     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.12.062     Document Type: Article

References (29)

1. Starzl T.E., Marchioro T.L., Rifkind D., et al. Factors in successful renal transplantation. Surgery 56 (1964) 296
2. Davidson J.A., and Wilkinson A. New-onset diabetes after transplantation 2003 international consensus guidelines: an endocrinologist's view. Diabetes Care 27 (2004) 805
3. Ruiz J.O., Simmons R.L., Callender C.O., et al. Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery 73 (1973) 759
4. Sumrani N.B., Delany V., Ding Z., et al. Diabetes mellitus after renal transplantation in cyclosporine era-an analysis of risk factors. Transplantation 51 (1991) 343
5. Montori V.M., Basu A., Erwin P.J., et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 25 (2002) 583
6. Reisaeter A.V., and Hartmann A. Risk factors and incidence of posttransplant diabetes mellitus. Trans Proc 33 Suppl 5A (2001) 8S
7. Bloom R.D., Rao V., Weng F., et al. Association of hepatitis C with posttransplant diabetes in renal transplantation patients on tacrolimus. J Am Soc Nephrol 13 (2002) 1374
8. Roth D., Milgrom M., Esquenazi V., et al. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 47 (1989) 278
9. Hathaway D.K., Tolley E.A., Blakely M.L., et al. Development of an index to predict posttransplant diabetes mellitus. Clin Transplant 7 (1993) 330
10. Midtvedt K., Hjelmesaeth J., Hartmann A., et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 15 (2004) 3233
11. Hjelmesaeth J., Midtvedt K., Jenssen T., et al. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. Diabetes Care 24 (2001) 2121
12. Nam J.H., Mun J.I., Kim S., et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 71 (2001) 1417
13. Hjelmesaeth J., Hagen M., Hartmann A., et al. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant 16 (2002) 389
14. Miles A.M., Sumrani N., Horowitz R., et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?. Transplantation 65 (1998) 380
15. Fellstrom B. Risk factors for and management of post-transplantation cardiovascular disease. Biodrugs 15 (2001) 261
16. Lindholm A., Albrechtsen D., Frodin L., et al. Ischemic heart disease-major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60 (1995) 451
17. Hjelmesaeth J., Hartmann A., Midtvedt K., et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 16 (2001) 1047
18. Kasiske B.L., Chakkera H.A., and Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11 (2000) 1735
19. Thomas M.C., Moran J., Mathew T.H., et al. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrol 1 (2000) 1
20. Boudreaux J.P., McHugh L., and Canafax D.M. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 44 (1987) 376
21. Hricick D.E., Bartucci M.R., Moir E.J., et al. Effects of steroid withdrawal on post-transplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 51 (1999) 374
22. Araki M., Flechner S.M., Ismail H.R., et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation 81 (2006) 335
23. Cosio F.G., Kudva Y., van der Velde M., et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 67 (2005) 2415
24. Benhamou P.Y., and Penfornis A. Natural history, prognosis and management of transplantation-induced diabetes mellitus. Diabetes Metab 28 (2002) 166
25. Davidson J., Wilkinson A., Dantal J., et al. International expert panel. New-onset diabetes after transplantation: 2003 international consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75 10 Suppl (2003) SS3
26. Yusuf S., Gerstein H., Hoogwerf B., et al. Ramipril and the development of diabetes. JAMA 286 (2001) 1882
27. Yusuf S., Ostergren J.B., Gerstein H.C., et al. Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation 112 (2005) 48
28. Prasad G.V., Kim S.J., Huang M., et al. Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins). Am J Transplant 4 (2004) 1897
29. Sumrani N., Delaney V., Ding Z., et al. Posttransplant diabetes mellitus in cyclosporine- treated renal transplant recipients. Transplant Proc 23 (1991) 1249